Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation

Abstract

Immunoincompetence after allogeneic hematopoietic stem cell transplantation (HSCT) affects in particular the T-cell lineage and is associated with an increased risk for infections, graft failure and malignant relapse. To generate large numbers of T-cell precursors for adoptive therapy, we cultured mouse hematopoietic stem cells (HSCs) in vitro on OP9 mouse stromal cells expressing the Notch-1 ligand Delta-like-1 (OP9-DL1). We infused these cells, together with T-cell–depleted mouse bone marrow or purified HSCs, into lethally irradiated allogeneic recipients and determined their effect on T-cell reconstitution after transplantation. Recipients of OP9-DL1–derived T-cell precursors showed increased thymic cellularity and substantially improved donor T-cell chimerism (versus recipients of bone marrow or HSCs only). OP9-DL1–derived T-cell precursors gave rise to host-tolerant CD4+ and CD8+ populations with normal T-cell antigen receptor repertoires, cytokine secretion and proliferative responses to antigen. Administration of OP9-DL1–derived T-cell precursors increased resistance to infection with Listeria monocytogenes and mediated significant graft-versus-tumor (GVT) activity but not graft-versus-host disease (GVHD). We conclude that the adoptive transfer of OP9-DL1–derived T-cell precursors markedly enhances T-cell reconstitution after transplantation, resulting in GVT activity without GVHD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Coculture of HSCs on OP9-DL1 cells results in large numbers of T-cell precursors, including DN2 cells, that engraft in the thymus of allogeneic HSCT recipients.
Figure 2: OP9-DL1–derived T-cell precursors significantly improve thymic and peripheral T-cell reconstitution after allogeneic HSCT.
Figure 3: Combined T-cell precursor and KGF administration has additive effects on thymic reconstitution after allogeneic HSCT, and OP9-DL1–derived T-cell precursors enhance intestinal T-cell development in thymectomized mice after allogeneic HSCT.
Figure 4: OP9-DL1–derived T cells have a diverse TCR repertoire, give an intact proliferative response in a third-party MLR and increase their cytokine secretion upon stimulation.
Figure 5: Adoptive transfer of OP9-DL1–derived T-cell precursors enhances resistance to L. monocytogenes after allogeneic HSCT.
Figure 6: OP9-DL1–derived T-cell precursors do not induce GVHD but promote GVT.

Similar content being viewed by others

References

  1. Kernan, N.A. et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N. Engl. J. Med. 328, 593–602 (1993).

    Article  CAS  Google Scholar 

  2. Ochs, L. et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood 86, 3979–3986 (1995).

    CAS  PubMed  Google Scholar 

  3. Hongeng, S. et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet 350, 767–771 (1997).

    Article  CAS  Google Scholar 

  4. Hansen, J.A. et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N. Engl. J. Med. 338, 962–968 (1998).

    Article  CAS  Google Scholar 

  5. Small, T.N. et al. Comparison of immune reconstitution after unrelated and related T-cell- depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 93, 467–480 (1999).

    CAS  PubMed  Google Scholar 

  6. van den Brink, M.R., Alpdogan, O. & Boyd, R.L. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat. Rev. Immunol. 4, 856–867 (2004).

    Article  CAS  Google Scholar 

  7. Keever, C.A. et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 73, 1340–1350 (1989).

    CAS  PubMed  Google Scholar 

  8. Storek, J., Witherspoon, R.P. & Storb, R. T-cell reconstitution after bone marrow transplantation into adult patients does not resemble T-cell development in early life. Bone Marrow Transplant. 16, 413–425 (1995).

    CAS  PubMed  Google Scholar 

  9. Radtke, F. et al. Notch regulation of lymphocyte development and function. Nat. Immunol. 5, 247–253 (2004).

    Article  CAS  Google Scholar 

  10. Harman, B.C., Jenkinson, E.J. & Anderson, G. Microenvironmental regulation of Notch signalling in T-cell development. Semin. Immunol. 15, 91–97 (2003).

    Article  CAS  Google Scholar 

  11. Schmitt, T.M. & Zuniga-Pflucker, J.C. Induction of T-cell development from hematopoietic progenitor cells by Delta-like-1 in vitro. Immunity 17, 749–756 (2002).

    Article  CAS  Google Scholar 

  12. Zuniga-Pflucker, J.C. T-cell development made simple. Nat. Rev. Immunol. 4, 67–72 (2004).

    Article  CAS  Google Scholar 

  13. Schmitt, T.M. et al. Induction of T-cell development and establishment of T-cell competence from embryonic stem cells differentiated in vitro. Nat. Immunol. 5, 410–417 (2004).

    Article  CAS  Google Scholar 

  14. La Motte-Mohs, R.N., Herer, E. & Zuniga-Pflucker, J.C. Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 105, 1431–1439 (2005).

    Article  CAS  Google Scholar 

  15. De Smedt, M., Hoebeke, I. & Plum, J. Human bone marrow CD34+ progenitor cells mature to T-cells on OP9-DL1 stromal cell line without thymus microenvironment. Blood Cells Mol. Dis. 33, 227–232 (2004).

    Article  CAS  Google Scholar 

  16. Balciunaite, G., Ceredig, R., Fehling, H.J., Zuniga-Pflucker, J.C. & Rolink, A.G. The role of Notch and IL-7 signaling in early thymocyte proliferation and differentiation. Eur. J. Immunol. 35, 1292–1300 (2005).

    Article  CAS  Google Scholar 

  17. Huang, J. et al. Propensity of adult lymphoid progenitors to progress to DN2/3 stage thymocytes with Notch receptor ligation. J. Immunol. 175, 4858–4865 (2005).

    Article  CAS  Google Scholar 

  18. Ikawa, T., Kawamoto, H., Fujimoto, S. & Katsura, Y. Commitment of common T/natural killer (NK) progenitors to unipotent T and NK progenitors in the mouse fetal thymus revealed by a single progenitor assay. J. Exp. Med. 190, 1617–1626 (1999).

    Article  CAS  Google Scholar 

  19. Schmitt, T.M., Ciofani, M., Petrie, H.T. & Zuniga-Pflucker, J.C. Maintenance of T-cell specification and differentiation requires recurrent Notch receptor-ligand interactions. J. Exp. Med. 200, 469–479 (2004).

    Article  CAS  Google Scholar 

  20. Danilenko, D.M. Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol. Pathol. 27, 64–71 (1999).

    Article  CAS  Google Scholar 

  21. Danilenko, D.M. et al. Keratinocyte growth factor alters thymocyte development via stimulation of thymic epithelial cells. FASEB J. 10, A1148 (1996).

    Google Scholar 

  22. Perales, M.A. et al. DNA immunization against melanoma antigens enhances tumor immunity after allogeneic hematopoietic stem cell transplantation. J. Immunol. (in the press).

  23. Cooke, K.R. et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88, 3230–3239 (1996).

    CAS  PubMed  Google Scholar 

  24. Foss, D.L., Donskoy, E. & Goldschneider, I. The importation of hematogenous precursors by the thymus is a gated phenomenon in normal adult mice. J. Exp. Med. 193, 365–374 (2001).

    Article  CAS  Google Scholar 

  25. Prockop, S.E. & Petrie, H.T. Regulation of thymus size by competition for stromal niches among early T-cell progenitors. J. Immunol. 173, 1604–1611 (2004).

    Article  CAS  Google Scholar 

  26. Min, D. et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99, 4592–4600 (2002).

    Article  CAS  Google Scholar 

  27. Rossi, S. et al. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 100, 682–691 (2002).

    Article  CAS  Google Scholar 

  28. Alpdogan, O. et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 107, 2453–2460 (2006).

    Article  CAS  Google Scholar 

  29. Guy-Grand, D. et al. Extrathymic T-cell lymphopoiesis: ontogeny and contribution to gut intraepithelial lymphocytes in athymic and euthymic mice. J. Exp. Med. 197, 333–341 (2003).

    Article  CAS  Google Scholar 

  30. Lambolez, F. et al. The thymus exports long-lived fully committed T-cell precursors that can colonize primary lymphoid organs. Nat. Immunol. 7, 76–82 (2006).

    Article  CAS  Google Scholar 

  31. Terszowski, G. et al. Evidence for a functional second thymus in mice. Science 312, 284–287 (2006).

    Article  CAS  Google Scholar 

  32. Porter, D.L. & Antin, J.H. The graft-versus-leukemia effects of allogeneic cell therapy. Annu. Rev. Med. 50, 369–386 (1999).

    Article  CAS  Google Scholar 

  33. Yang, Y.G., Qi, J., Wang, M.G. & Sykes, M. Donor-derived interferon γ separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T-cells. Blood 99, 4207–4215 (2002).

    Article  CAS  Google Scholar 

  34. Chen, B.J., Cui, X., Sempowski, G.D., Domen, J. & Chao, N.J. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood 103, 4344–4352 (2004).

    Article  CAS  Google Scholar 

  35. BitMansour, A. et al. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood 100, 4660–4667 (2002).

    Article  CAS  Google Scholar 

  36. Arber, C. et al. Common lymphoid progenitors rapidly engraft and protect against lethal mouse cytomegalovirus infection after hematopoietic stem cell transplantation. Blood 102, 421–428 (2003).

    Article  CAS  Google Scholar 

  37. Delaney, C., Varnum-Finney, B., Aoyama, K., Brashem-Stein, C. & Bernstein, I.D. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood 106, 2693–2699 (2005).

    Article  CAS  Google Scholar 

  38. Dallas, M.H., Varnum-Finney, B., Delaney, C., Kato, K. & Bernstein, I.D. Density of the Notch ligand Delta1 determines generation of B and T-cell precursors from hematopoietic stem cells. J. Exp. Med. 201, 1361–1366 (2005).

    Article  CAS  Google Scholar 

  39. Terwey, T.H. et al. CC chemokine receptor 2 is required for CD8-induced graft-versus-host disease. Blood 106, 3322–3330 (2005).

    Article  CAS  Google Scholar 

  40. Schmaltz, C. et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T-cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 97, 2886–2895 (2001).

    Article  CAS  Google Scholar 

  41. Petrovic, A. et al. LPAM (α4β7 integrin) is an important homing integrin on alloreactive T-cells in the development of intestinal graft-versus-host disease. Blood 103, 1542–1547 (2004).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the staff of the Research Animal Resource Center for animal care. This work was supported by grants HL69929, CA33049 and CA107096 from the US National Institutes of Health, by awards from the Leukemia and Lymphoma Society the Emerald Foundation and The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center funded by Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research (M.R.M.v.d.B.), P20-CA103694 from the National Institutes of Health (Ö.A.), Dr. Werner Jackstaedt Stiftung (J.L.Z.), Deutsche Forschungsgemeinschaft (J.L.Z.), Deutscher Akademischer Austausch Dienst (T.H.T.), Boehringer Ingelheim Fonds (T.H.T.) and Deutsche Krebshilfe (T.D.K.). Ö.A. is the recipient of the Amy Strelzer Manasevit Scholar Award from The National Marrow Donor Program (NMDP) and The Marrow Foundation. J.C.Z.P. is supported by a Canada Research Chair in Developmental Immunology.

Author information

Authors and Affiliations

Authors

Contributions

J.L.Z. designed experiments, performed animal studies and tissue culture, analyzed data, generated figures and wrote the manuscript. A.A.K, S.X.L., T.H.T., T.D.K, V.M.H., S.J.M., D.S, O.M.S, J.G., N.P., A.C., J.C.P., and R.R. assisted with performance of transplantations, HSC sorting, organ harvests, in vivo BLI, GVHD scoring and tissue culture. A.D. and M.A.P. designed and performed vaccination experiments and G.R. performed ELISpot studies. E.M. assisted with L. monocytogenes studies and E.G.P. designed and analyzed L. monocytogenes experiments. G.H. performed statistical analyses and J.C.Z.-P. designed experiments and analyzed data. Ö.A. designed and performed experiments, analyzed data and supervised the study, and M.R.M.v.d.B. designed experiments, analyzed data, supervised the study and edited the manuscript.

Corresponding author

Correspondence to Marcel R M van den Brink.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

OP9-DL1 derived DN T-cell precursors upregulate several molecules involved in lymphocyte trafficking (PDF 501 kb)

Supplementary Fig. 2

Thymic engraftment of OP9-DL1 derived T-cell precursors after allogeneic HSCT is dose and time point dependent, and its effect on thymic reconstitution cannot be resembled by increasing the stem cell inoculum in the allograft (PDF 208 kb)

Supplementary Fig. 3

Adoptive transfer of OP9-DL1 derived precursor cells enhances early NK cell reconstitution in recipients of an allogeneic HSCT (PDF 129 kb)

Supplementary Fig. 4

T-cells from tumor bearing BMT recipients treated with OP9-DL1 derived T-cell precursors show an increased INF-γ response to stimulation with A20-TGL (PDF 100 kb)

Supplementary Fig. 5

NK cell are not required for GVT activity against A20-TGL mediated by OP9-DL1 derived precursor cells in allogeneic HSCT recipients (PDF 136 kb)

Supplementary Methods (PDF 123 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zakrzewski, J., Kochman, A., Lu, S. et al. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med 12, 1039–1047 (2006). https://doi.org/10.1038/nm1463

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1463

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing